Gut microbiota, metabolites and host immunity

Nature Reviews Immunology

Volumn 16, Issue 6, 2016, Pages 341-352

  Rooks, Michelle G ^a   Garrett, Wendy S ^a,b,c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; DEXTRO GLYCERO BETA DEXTRO MANNOHEPTOSE 1,7 BISPHOSPHATE; LIGAND; PEPTIDE; PHOSPHATE; POLYAMINE; POLYSACCHARIDE; POLYSACCHARIDE A; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG; FATTY ACID; PATTERN RECOGNITION RECEPTOR;

BIOCHEMICAL ANALYSIS; HOST; HUMAN; IMMUNITY; IMMUNOMODULATION; INTESTINE FLORA; METABOLITE; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMBIOSIS; ANIMAL; CYTOLOGY; DISEASE PREDISPOSITION; HOMEOSTASIS; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; METAGENOME; METAGENOMICS; MICROFLORA;

ANIMALS; DISEASE SUSCEPTIBILITY; FATTY ACIDS; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; METAGENOME; METAGENOMICS; MICROBIOTA; RECEPTORS, PATTERN RECOGNITION; SYMBIOSIS;

EID: 84971201113     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2016.42     Document Type: Review

References (126)

1. Ding T, & Schloss P. D. Dynamics and associations of microbial community types across the human body. Nature. 509, 357-360 (2014).
2. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 486, 207-214 (2012).
3. Eckburg P. B, et al. Diversity of the human intestinal microbial flora. Science. 308, 1635-1638 (2005).
4. Donaldson G. P, Lee S. M, & Mazmanian S. K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 14, 20-32 (2015).
5. Sender R, Fuchs S, & Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell. 164, 337-340 (2016).
6. Franzosa E. A, et al. Sequencing and beyond: integrating molecular 'omics' for microbial community profiling. Nat. Rev. Microbiol. 13, 360-372 (2015).
7. Blekhman R, et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol. 16, 191 (2015).
8. Morgan X. C, & Huttenhower C. Meta'omic analytic techniques for studying the intestinal microbiome. Gastroenterology. 146, 1437-1448 (2014).
9. Dianda L, et al. T cell receptor-αβ-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150, 91-97 (1997).
10. Sellon R. K, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin 10 deficient mice. Infect. Immun. 66, 5224-5231 (1998).
11. Reháková Z, et al. Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum. Immunol. 61, 555-558 (2000).
12. Sudo N, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-Adrenal system for stress response in mice. J. Physiol. 558, 263-275 (2004).
13. Bohn E, et al. Host gene expression in the colon of gnotobiotic interleukin 2 deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures. Inflamm. Bowel Dis. 12, 853-862 (2006).
14. Wen L, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature. 455, 1109-1113 (2008).
15. Wu H. J, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 32, 815-827 (2010).
16. Garrett W. S, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 8, 292-300 (2010).
17. Berer K, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 479, 538-541 (2011).
18. Lee Y. K, Menezes J. S, Umesaki Y, & Mazmanian S. K. Proinflammatory T cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4615-4622 (2011).
19. Melkus M. W, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST 1. Nat. Med. 12, 1316-1322 (2006).
20. Nochi T, Denton P. W, Wahl A, & Garcia J. V. Cryptopatches are essential for the development of human GALT. Cell Rep. 3, 1874-1884 (2013).
21. Laukens D, Brinkman B. M, Raes J, De Vos M, & Vandenabeele P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol. Rev. 40, 117-132 (2016).
22. Lichtman J. S, Marcobal A, Sonnenburg J. L, & Elias J. E. Host-centric proteomics of stool: a novel strategy focused on intestinal responses to the gut microbiota. Mol. Cell Proteom. 12, 3310-3318 (2013).
23. Marcobal A, et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J 7 1933-1943 (2013).
24. Sridharan G. V, et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat. Commun. 5, 5492 (2014).
25. Kolmeder C. A, & de Vos W. M. Metaproteomics of our microbiome - developing insight in function and activity in man and model systems. J. Proteomics. 97, 3-16 (2014).
26. Xiong W, Abraham P. E, Li Z, Pan C, & Hettich R. L. Microbial metaproteomics for characterizing the range of metabolic functions and activities of human gut microbiota. Proteomics. 15, 3424-3438 (2015).
27. Lasken R. S, & McLean J. S. Recent advances in genomic DNA sequencing of microbial species from single cells. Nat. Rev. Genet. 15, 577-584 (2014).
28. Cleary B, et al. Detection of low-Abundance bacterial strains in metagenomic datasets by eigengenome partitioning. Nat. Biotechnol. 33, 1053-1060 (2015).
29. Luo C, et al. ConStrains identifies microbial strains in metagenomic datasets. Nat. Biotechnol. 33, 1045-1052 (2015).
30. Ufarté L, Potocki-Veronese G, & Laville É. Discovery of new protein families and functions: new challenges in functional metagenomics for biotechnologies and microbial ecology. Front. Microbiol. 6, 563 (2015).
31. Earle K. A, et al. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe. 18, 478-488 (2015).
32. Geva-Zatorsky N, et al. In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nat. Med. 21, 1091-1100 (2015).
33. Hooper L. V, Midtvedt T, & Gordon J. I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307 (2002).
34. Cummings J. H, Pomare E. W, Branch W. J, Naylor C. P, & Macfarlane G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 28, 1221-1227 (1987).
35. Usami M, et al. Butyrate and trichostatin A attenuate nuclear factor ?B activation and tumor necrosis factor α secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr. Res. 28, 321-328 (2008).
36. Vinolo M. A. R, et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22, 849-855 (2011).
37. Kendrick S. F. W, et al. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology. 51, 1988-1997 (2010).
38. Chang P. V, Hao L, Offermanns S, & Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl Acad. Sci. USA. 111, 2247-2252 (2014).
39. Singh N, et al. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J. Biol. Chem. 285, 27601-27608 (2010).
40. Trompette A, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159-166 (2014).
41. Tao R, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299-1307 (2007).
42. Furusawa Y, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 504, 446-450 (2013).
43. Arpaia N, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation. Nature. 504, 451-455 (2013).
44. Smith P. M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 341, 569-573 (2013).
45. Thorburn A. N, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat. Commun. 6, 7320 (2015).
46. Maslowski K. M, & Mackay C. R. Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5-9 (2011).
47. Wang L, de Zoeten E. F, Greene M. I, & Hancock W. W. Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nat. Rev. Drug Discov. 8, 969-981 (2009).
48. Thorburn A. N, Macia L, & Mackay C. R. Diet, metabolites, and 'western-lifestyle' inflammatory diseases. Immunity. 40, 833-842 (2014).
49. Maslowski K. M, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 461, 1282-1286 (2009).
50. Voltolini C, et al. A novel antiinflammatory role for the short-chain fatty acids in human labor. Endocrinology 153 395-403 (2012).
51. Vieira A. T, et al. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol 67 1646-1656 (2015).
52. Erny D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965-977 (2015).
53. Singh N, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 40, 128-139 (2014).
54. Ghorbani P, et al. Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth. Eur. Respir. J. 46, 1033-1045 (2015).
55. Willemsen L. E. M, Koetsier M. A, van Deventer S. J. H, & van Tol E. A. F. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut. 52, 1442-1447 (2003).
56. Gaudier E, et al. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1168-G1174 (2004).
57. Wrzosek L, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 11, 61 (2013).
58. Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 469, 543-547 (2011).
59. Macia L, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 6, 6734 (2015).
60. Elinav E, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 145, 745-757 (2011).
61. Schilderink R, Verseijden C, & de Jonge W. J. Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front. Immunol. 4, 226 (2013).
62. Wu J, Zhou Z, Hu Y, & Dong S. Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. J. Genet. Genom. 39, 375-384 (2012).
63. Li Y, et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell. 147, 629-640 (2011).
64. Kiss E. A, et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science. 334, 1561-1565 (2011).
65. Zelante T, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin 22. Immunity. 39, 372-385 (2013).
66. Hubbard T. D, et al. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep. 5, 12689 (2015).
67. Di Martino M. L, et al. Polyamines: emerging players in bacteria-host interactions. Int. J. Med. Microbiol. 303, 484-491 (2013).
68. Chen J, et al. Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G568-G576 (2007).
69. Liu L, et al. Polyamines regulate E cadherin transcription through c Myc modulating intestinal epithelial barrier function. Am. J. Physiol. Cell Physiol. 296, C801-C810 (2009).
70. Dufour C, et al. Spermine and spermidine induce intestinal maturation in the rat. Gastroenterology. 95, 112-116 (1988).
71. Buts J. P, De Keyser N, Kolanowski J, Sokal E, & Van Hoof F. Maturation of villus and crypt cell functions in rat small intestine. Role of dietary polyamines. Dig. Dis. Sci. 38, 1091-1098 (1993).
72. Löser C, Eisel A, Harms D, & Fölsch U. R. Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development. Gut. 44, 12-16 (1999).
73. Zhang M, Wang H, & Tracey K. J. Regulation of macrophage activation and inflammation by spermine: a new chapter in an old story. Crit. Care Med. 28, N60-N66 (2000).
74. Kibe R, et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice. Sci. Rep. 4, 4548 (2014).
75. Perez-Cano F. J, González-Castro A, Castellote C, Franch A, & Castell M. Influence of breast milk polyamines on suckling rat immune system maturation. Dev. Comp. Immunol. 34, 210-218 (2010).
76. Minois N, Carmona-Gutierrez D, & Madeo F. Polyamines in aging and disease. Aging (Albany NY). 3, 716-732 (2011).
77. Matsumoto M, Kurihara S, Kibe R, Ashida H, & Benno Y. Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS ONE 6, e23652 (2011).
78. Miller-Fleming L, Olin-Sandoval V, Campbell K, & Ralser M. Remaining mysteries of molecular biology: the role of polyamines in the cell. J. Mol. Biol. 427, 3389-3406 (2015).
79. Gerner E. W, & Meyskens F. L. Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer. 4, 781-792 (2004).
80. Johnson C. H, et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell. Metab. 21, 891-897 (2015).
81. Hayes C. S, et al. Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. Cancer Immunol. Res. 2, 274-285 (2014).
82. Wang Q, et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp. Med. 203, 2853-2863 (2006).
83. Mazmanian S. K, Liu C. H, Tzianabos A. O, & Kasper D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 122, 107-118 (2005).
84. Dasgupta S, Erturk-Hasdemir D, Ochoa-Repáraz J, Reinecker H. C, & Kasper D. L. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe. 15, 413-423 (2014).
85. Mazmanian S. K, Round J. L, & Kasper D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 620-625 (2008).
86. Round J. L, et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 332, 974-977 (2011).
87. Wang Y, et al. A commensal bacterial product elicits and modulates migratory capacity of CD39+ CD4 T regulatory subsets in the suppression of neuroinflammation. Gut Microbes 5 552-561 (2014).
88. Dwyer K. M, et al. CD39 and control of cellular immune responses. Purinerg. Signal. 3, 171-180 (2007).
89. Telesford K. M, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+Foxp3+ T cells and Treg function. Gut Microbes 6 234-242 (2015).
90. Gibson D. J, et al. Heightened expression of CD39 by regulatory T lymphocytes is associated with therapeutic remission in inflammatory bowel disease. Inflamm. Bowel Dis. 21, 2806-2814 (2015).
91. Liu M, et al. Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing. PLoS ONE 9, e90613 (2014).
92. Kretschmer D, Rautenberg M, Linke D, & Peschel A. Peptide length and folding state govern the capacity of staphylococcal β type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2. J. Leukoc. Biol. 97, 689-697 (2015).
93. Bloes D. A, Kretschmer D, & Peschel A. Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors. Nat. Rev. Microbiol. 13, 95-104 (2015).
94. Chiu I. M, et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature. 501, 52-57 (2013).
95. Haas P. J, et al. N terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J. Immunol 173 5704-5711 (2004).
96. Prat C, et al. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. J. Immunol 183 6569-6578 (2009).
97. Yang S, et al. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria. Eur. J. Med. Chem. 86, 133-152 (2014).
98. Lewandowski T, et al. Staphylococcus aureus formyl-methionyl transferase mutants demonstrate reduced virulence factor production and pathogenicity. Antimicrob. Agents Chemother. 57, 2929-2936 (2013).
99. Min S, et al. Frequency of spontaneous resistance to peptide deformylase inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. Antimicrob. Agents Chemother. 59, 4644-4652 (2015).
100. Gaudet R. G, et al. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity. Science. 348, 1251-1255 (2015).
101. Maricic T, Whitten M, & Pääbo S. Multiplexed DNA sequence capture of mitochondrial genomes using PCR products. PLoS ONE 5, e14004 (2010).
102. Burbano H. A, et al. Targeted investigation of the Neandertal genome by array-based sequence capture. Science. 328, 723-725 (2010).
103. Duncavage E. J, et al. Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue. J. Mol. Diagn. 13, 325-333 (2011).
104. Cabanski C. R, et al. cDNA hybrid capture improves transcriptome analysis on low-input and archived samples. J. Mol. Diagn. 16, 440-451 (2014).
105. Lim S. W, Tran T. M, & Abate A. R. PCR-Activated cell sorting for cultivation-free enrichment and sequencing of rare microbes. PLoS ONE 10, e0113549 (2015).
106. Maurice C. F, & Turnbaugh P. J. Quantifying the metabolic activities of human-Associated microbial communities across multiple ecological scales. FEMS Microbiol. Rev. 37, 830-848 (2013).
107. Segata N, et al. Computational meta'omics for microbial community studies. Mol. Syst. Biol. 9, 666 (2013).
108. Faith J. J, et al. Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J. 4, 1094-1098 (2010).
109. Wostmann B. S, Larkin C, Moriarty A, & Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab. Anim. Sci. 33, 46-50 (1983).
110. Rosenbaum M, Knight R, & Leibel R. L. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metab. 26, 493-501 (2015).
111. Deplancke B, & Gaskins H. R. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 73, 1131S-1141S (2001).
112. Smith K, McCoy K. D, & Macpherson A. J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 19, 59-69 (2007).
113. Pabst O. New concepts in the generation and functions of IgA. Nat. Rev. Immunol. 12, 821-832 (2012).
114. Ivanov I. I, et al. Specific microbiota direct the differentiation of IL 17 producing T helper cells in the mucosa of the small intestine. Cell Host Microbe. 4, 337-349 (2008).
115. Strauch U. G, et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut. 54, 1546-1552 (2005).
116. Belkaid Y, & Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat. Immunol. 14, 646-653 (2013).
117. Borre Y. E, et al. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol. Med. 20, 509-518 (2014).
118. Belcheva A, et al. Gut microbial metabolism drives transformation of MSH2 deficient colon epithelial cells. Cell. 158, 288-299 (2014).
119. Donohoe D. R, et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- And butyrate-dependent manner. Cancer Discov 4 1387-1397 (2014).
120. Srinivasan S, et al. Metabolic signatures of bacterial vaginosis. MBio 6, e00204-00215 (2015).
121. Koeth R. A, et al. Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576-585 (2013).
122. Pluznick J. L, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc. Natl Acad. Sci. USA. 110, 4410-4415 (2013).
123. Meijers B. K. I, et al. p Cresol and cardiovascular risk in mild to moderate kidney disease. Clin. J. Am. Soc. Nephrol. 5, 1182-1189 (2010).
124. Hsiao E. Y, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 155, 1451-1463 (2013).
125. Braniste V, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl Med. 6, 263ra158 (2014).
126. Buffie C. G, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 517, 205-208 (2015).